MaxGen Scientific Consulting Group
Vision
MaxGen Scientific Consulting Group partners with labs, startups, and schools to design better experiments, strengthen microbiology and molecular biology capabilities, and build effective training and curriculum. Our goal is to help you generate clear, defensible data and give your teams the knowledge they need to use it.
Expertise
Our team stands out with a rich reservoir of expertise across diverse domains such as biotechnology, project management, and education. Drawing from years of hands-on experience in both industry and academia, our experts bring together a range of perspectives and skills. This powerful amalgamation not only enables us to tackle comp
Our team stands out with a rich reservoir of expertise across diverse domains such as biotechnology, project management, and education. Drawing from years of hands-on experience in both industry and academia, our experts bring together a range of perspectives and skills. This powerful amalgamation not only enables us to tackle complex challenges but also empowers us to create innovative solutions that surpass expectations.
Responsibility
Responsibility
Responsibility
Transparency and measurable results guide every project. We communicate clearly about scope and progress, and we define what success looks like—whether that is a functioning assay, a completed validation study, or a deployed training program. Our aim is to leave you with tools and knowledge that continue to provide value long after the engagement ends.
People
Responsibility
Responsibility
Manji Gunawardana, MPH, began his career in biotechnology at a startup focused on enzyme catalysis, gaining hands‑on experience in applied biochemistry and product development. After the company merged with a mid‑sized, NASDAQ‑listed pharmaceutical firm, he transitioned to a non‑profit academic research institute, where he led the
Manji Gunawardana, MPH, began his career in biotechnology at a startup focused on enzyme catalysis, gaining hands‑on experience in applied biochemistry and product development. After the company merged with a mid‑sized, NASDAQ‑listed pharmaceutical firm, he transitioned to a non‑profit academic research institute, where he led the creation of a microbiology and molecular biology research team. In that role, he directed NIH‑ and USAID‑funded projects and mentored emerging scientists, blending rigorous research with a strong commitment to training the next generation.